| 1 Overall survival |
3 |
781 |
Hazard Ratio (Random, 95% CI) |
0.80 [0.61, 1.06] |
| 1.1 General Surgeons or less extensive primary surgery |
2 |
357 |
Hazard Ratio (Random, 95% CI) |
0.68 [0.53, 0.87] |
| 1.2 Gynaecologic oncologists |
1 |
424 |
Hazard Ratio (Random, 95% CI) |
0.99 [0.79, 1.24] |
| 2 Progression‐free survival |
2 |
702 |
Hazard Ratio (Random, 95% CI) |
0.88 [0.57, 1.33] |
| 3 Toxic reactions to chemotherapy |
2 |
357 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.19 [0.53, 2.66] |
| 4 Peripheral neuropathy of grade 2 or higher |
1 |
|
Risk Ratio (IV, Random, 95% CI) |
Subtotals only |
| 5 Grade 3 or 4 gastrointestinal adverse events |
1 |
|
Risk Ratio (IV, Random, 95% CI) |
Subtotals only |
| 6 Grade 4 pulmonary adverse events |
1 |
|
Risk Ratio (IV, Random, 95% CI) |
Subtotals only |
| 7 Grade 4 cardiovascular adverse events |
1 |
|
Risk Ratio (IV, Random, 95% CI) |
Subtotals only |
